|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C12N 5/20 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2068921 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07868508.8 |
| Date of filing the European patent application | 2007-10-19 | |
| (97) | Date of publication of the European application | 2009-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/081879 |
| Date | 2007-10-19 |
| (87) | Number | WO 2008/060813 |
| Date | 2008-05-22 |
| (30) | Number | Date | Country code |
| 852884 P | 2006-10-19 | US |
| (72) |
NASH, Andrew Donald, AU
BACA, Manuel, US
FABRI, Louis Jerry, AU
ZALLER, Dennis, US
STROHL, William R., US
AN, Zhiqiang, US
|
| (73) |
CSL Limited,
45 Poplar Road, Parkville VIC 3052,
AU
|
| (54) | HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1 |
| HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1 |